Modulations of the effector function and cytokine production of human lymphocytes by secreted factors derived from colorectal-carcinoma cells

International Journal of Cancer

Volumn 72, Issue 1, 1997, Pages 142-148

  Luo, Jian S ^a   Kammerer, Robert ^a   Schultze, Henning ^a   Von Kleist, Sabine ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LYMPHOCYTE PROLIFERATION; LYMPHOKINE ACTIVATED KILLER CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; SECRETION; SUPERNATANT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

COLORECTAL NEOPLASMS; CYTOKINES; FREEZING; HEAT; HUMANS; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PHYTOHEMAGGLUTININS; TUMOR CELLS, CULTURED;

EID: 0030741278     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970703)72:1<142::AID-IJC20>3.0.CO;2-K     Document Type: Article

References (28)

1. ALLEN, P.D., JOHNSTON, D.H., MACEY, M.G., WILLIAMS, N.S. and NEWLAND, A.C., Colorectal-cell-line suppression of lymphokine-activated killer-cell generation is reversed by suramin. Anti-Cancer Drugs, 6, 250-258 (1995).
2. BLOMBERG, K., GRANBERG, C., HEMMILA, I. and LOVGREN, T., Europium-labeled target cells in an assay of natural-killer-cell activity. I. A novel non-radioactive method based on time-resolved fluorescence. J. immunol. Meth., 86, 225-229 (1986).
3. CRABTREE, G.R., Contingent genetic regulatory events in T-lymphocyte activation. Science, 243, 355-361 (1989).
4. DING, L., ISOBE, K., YOSHIDA, T. and NAKASHIMA, I., Suppression of lymphocyte-signal transduction by murine mastocytoma ascites. Microbiol. Immunol., 35, 767-774 (1991).
5. EBERT, B.C., ROBERTS, A.I., DEVEREUX, D. and NAGASE, H., Selective immunosuppressive action of a factor produced by colon-cancer cells Cancer Res., 50, 6158-6161 (1990).
6. EBERT, B.C., ROBERTS, A.I., O'CONNELL, S.M., ROBERTSON, F.M. and NAGASE, H., Characterization of an immunosuppressive factor derived from colon-cancer cells. J. Immunol., 138, 2161-2168 (1987).
7. ELSÄSSER-BEILE, U., VON KLEIST, S., FISCHER, R. and MÖNTING, J.S., Impaired cytokine production in whole-blood cell cultures from patients with colorectal carcinomas as compared to benign colorectal tumors and controls. J. Clin. Lab. Anal., 6, 311-314 (1992).
8. ELSÄSSER-BEILE, U., VON KLEIST, S., SAUTHER, W., GALLATI, H. and MÖNTING, J.S., Impaired cytokine production in whole-blood cell cultures of patients with gynaecological carcinomas in different clinical stages. Brit. J. Cancer, 68, 32-36 (1993).
9. GALLATI, H., PRACHT, I., SCHMIDT, J., MÄRING, P. and GAROTTA, G., A simple, rapid and large-capacity ELISA for biologically active native and recombinant human IFNγ. J. biol. Regul. homeost. Agents, 1, 109-118 (1987).
10. GUILLOU, P.J., RAMSDEN, C.W., SOMERS, S.S. and SEDMAN, P.C., Suppression of the generation of lymphokine-activated-killer(LAK) cells by serum-free supernatants of in vitro-maintained tumor cell lines. Brit. J. Cancer, 59, 515-521 (1989).
11. HOSKIN, D.W., REYNOLDS, T. and BLAY, J., Colon adenocarcinoma cells inhibit anti-CD3-activated killer cell induction. Cancer Immunol. Immunother., 38, 201-207 (1994).
12. KAMMERER, R. and VON KLEIST, S., CEA expression of colorectal adenocarcinomas is correlated with their resistance against LAK-cell lysis. Int. J. Cancer, 57, 341-347 (1994).
13. MATSUDA, M., PETERSSON, M., LENKEI, R., TAUPIN, J.L., MAGNUSSON, I., MELLSTEDT, H., ANDERSON, P. and KIESSLING, R., Alterations in the signal-transducing molecules of T cells and NK cells in colorectal-tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int. J. Cancer, 61, 765-772 (1995).
14. MINAMI, T. and TANIGUCHI, T., IL-2 signaling: recruitment and activation of multiple protein tyrosine kinases by the components of the IL-2 receptor. Curr. Opin. Cell Biol., 7, 156-162 (1995).
15. MIZOGUCHI, H., O'SHEA, J.J., LONGO, D.L., LOEFFLER, C.M., MCVICAR, D.W. and OCHOA, A.C., Alterations in signal-transduction molecules in T lymphocytes from tumor-bearing mice. Science, 258, 1795-1798 (1992).
16. MORI, N., YAMASHITA, U., TANAKA, Y., NAGATA, K., NAKATA, K., ODA, S. and ETO, S., Immunosuppressive factor produced by a B-cell line derived from an adult T-cell-leukemia patient. Int. J. Hematol., 56, 29-39 (1992).
17. O'MAHONY, A.M., O'SULLIVAN, G.C., O'CONNELL, J., COTTER, T.G. and COLLINS, J.K., An immune-suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J. Immunol., 151, 4847-4856 (1993).
18. RICE, S.Q., CRANE, I.J., SCULLY, C. and PRIME, S.S., Production of a suppressor of lymphocyte proliferation by two human oral-carcinoma cell lines. Scand. J. Immunol., 36, 443-452 (1992).
19. RIGG, K.M., SHENTON. B.K., BROTHERICK, I., TAYLOR, R.M. and LENNARD, T.W., Alterations in circulating lymphocyte number and function after circulation through colorectal carcinomas. Surgery, 109, 747-755 (1991).
20. ROBB, R.J., GREENE, W.C. and RUSK, C.M., Low- and high-affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J. exp. Med., 160, 1126-1146 (1984).
21. SHAHINIAN, A., PFEFFER, K., LEE, K.P., KUNDIG, T.M., KISHIHARA, K., WAKEHAM, A., KAWAI, K., OHASHI, P.S., THOMPSON, C.B. and MAK, T.W., Differential T-cell co-stimulatory requirements in CD28-deficient mice. Science, 261,609-612 (1993).
22. SHU, S., CHOU, T. and ROSENBERG, S.A., Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy. J. Immunol., 139, 295-304 (1987).
23. 1, phase with no influence on interleukin-2 production and interleukin-2-receptor-light-chain expression. Europ. J. Immunol., 19, 1357-1364 (1989).
24. SULITZEANU, D., Immunosuppressive factors in human cancer (Review). Advanc. Cancer Res., 60, 247-267 (1993).
25. WATANABE, N., HIZUTA, A., TANAKA, N. and ORITA, K., Localization of T-cell receptor(TCR)-gamma-delta + T cells into human colorectal cancer: flow-cytometric analysis of TCR-gamma-delta expression in tumorinfiltrating lymphocytes. Clin. exp. Immunol., 102, 167-173 (1995).
26. WHITEHEAD, J.S. and KIM, YS., An inhibitor of lymphocyte proliferation produced by human colonic-adenocarcinoma cell line in culture. Cancer Res., 40, 29-35 (1980).
27. YOSHINO, I., YANO, T, MURATA, M., ISHIDA, T., SUGIMACHI, K., KIMURA, G. and NOMOTO, K., Tumor-reactive T cells accumulate in lung-cancer tissues but fail to respond due to tumor-cell-derived factor. Cancer Res., 52, 775-781 (1992).
28. YOUNG, M.I., WRIGHT, M.A., LOZANO, Y. and MATTHEWS, J.P., Mechanisms of immune suppression in patients with head-and-neck cancer: influence on the immune infiltrate of the cancer. Int. J. Cancer, 67, 333-338 (1996).